Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Surescripts in Dispute With ReMy Health -CNBC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/11/2019 | 01:22pm EDT

--Surescripts, whose owners include CVS Health and Cigna Corp unit Express Scripts, said it has ended its relationship with ReMy Health amid a patient data dispute, to a CNBC report.

--According to the report, the issue affects Amazon unit PillPack, which has used ReMy to access medication history that Surescripts collected.

Full story: https://www.cnbc.com/2019/09/11/surescripts-makes-it-difficult-for-amazon-pillpack-to-access-patient-data.html

Write to Josh Beckerman at josh.beckerman@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
AMAZON.COM -0.23% 1839.34 Delayed Quote.22.74%
CIGNA CORP 1.18% 160.85 Delayed Quote.-15.31%
CVS HEALTH CORPORATION 0.25% 64.06 Delayed Quote.-2.23%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
09/13The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CV..
BU
09/13Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against CV..
BU
09/12CVS HEALTH : Google Photos and CVS Pharmacy Team Up to Offer Same-Day Printing a..
PR
09/11Surescripts in Dispute With ReMy Health -CNBC
DJ
09/09Walgreens Boots Alliance on Pace for Largest Percent Increase in Over a Year ..
DJ
09/09CVS HEALTH : American College of Rheumatology - Rheumatology Leaders Concerned C..
AQ
09/09AETNA : Voices of Health Competition Kicks Off Today
PR
09/06ALPHABET, MATCH GROUP, CVS : Stocks That Defined The Week
DJ
09/06GLOBAL MARKETS LIVE : CVS Health, Nissan, Deutsche Bank, Exxon Mobil…
09/05Walgreens, CVS Ask Customers to Stop Carrying Guns -- 2nd Update
DJ
More news
Financials (USD)
Sales 2019 253 B
EBIT 2019 15 012 M
Net income 2019 6 583 M
Debt 2019 63 327 M
Yield 2019 3,11%
P/E ratio 2019 12,6x
P/E ratio 2020 11,4x
EV / Sales2019 0,58x
EV / Sales2020 0,55x
Capitalization 83 310 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 71,58  $
Last Close Price 64,06  $
Spread / Highest target 43,6%
Spread / Average Target 11,7%
Spread / Lowest Target -9,46%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President